Procter & Gamble reported strong organic sales growth and broad-based category strength, highlighting effective pricing and share gains. However, ongoing cost headwinds and EPS guidance at the lower end may temper investor enthusiasm in the short term. The overall impact is likely to be slightly negative as cost pressures take precedence.

[-1]